Brown MA, Laval SH, Brophy S, Calin A. Recurrence risk modelling of the genetic susceptibility to ankylosing spondylitis. Ann Rheum Dis. 2000;59(11):883–6.
Article CAS PubMed PubMed Central Google Scholar
Pedersen OB, Svendsen AJ, Ejstrup L, Skytthe A, Harris JR, Junker P. Ankylosing spondylitis in Danish and Norwegian twins: occurrence and the relative importance of genetic vs. environmental effectors in disease causation. Scand J Rheumatol. 2008;37(2):120–6.
Article CAS PubMed Google Scholar
Costantino F, Breban M, Garchon HJ. Genetics and functional genomics of spondyloarthritis. Front Immunol. 2018;9:2933. Current overview of common and rare variants in SpA along with gene expression.
Article CAS PubMed PubMed Central Google Scholar
Wellcome Trust Case Control C, Australo-Anglo-American Spondylitis C, Burton PR, Clayton DG, Cardon LR, Craddock N, et al. Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants. Nat Genet. 2007;39(11):1329–37.
Osgood JA, Knight JC. Translating GWAS in rheumatic disease: approaches to establishing mechanism and function for genetic associations with ankylosing spondylitis. Brief Funct Genomics. 2018;17(5):308–18. Highlights strategic approaches for follow-up functional studies after identification of disease-associated variants.
CAS PubMed PubMed Central Google Scholar
Chimenti MS, Perricone C, D’Antonio A, Ferraioli M, Conigliaro P, Triggianese P, et al. Genetics, epigenetics, and gender impact in axial-spondyloarthritis susceptibility: an update on genetic polymorphisms and their sex related associations. Front Genet. 2021;12:671976. Evaluated genetic and epigenetic factors and their relationship with sex and bDMARDs response.
Article CAS PubMed PubMed Central Google Scholar
Motta F, Pederzani A, Carena MC, Ceribelli A, Wordsworth PB, De Santis M, et al. MicroRNAs in axial spondylarthritis: an overview of the recent progresses in the field with a focus on ankylosing spondylitis and psoriatic arthritis. Curr Rheumatol Rep. 2021;23(8):59. Reviews recent discoveries related to the role of microRNAs in ankylosing spondylitis, focusing on their expression profiling.
Article CAS PubMed PubMed Central Google Scholar
Choi SW, O'Reilly PF. PRSice-2: polygenic risk score software for biobank-scale data. GigaScience. 2019;8(7).
Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet. 2007;81(3):559–75.
Article CAS PubMed PubMed Central Google Scholar
Vilhjalmsson BJ, Yang J, Finucane HK, Gusev A, Lindstrom S, Ripke S, et al. Modeling linkage disequilibrium increases accuracy of polygenic risk scores. Am J Hum Genet. 2015;97(4):576–92.
Article CAS PubMed PubMed Central Google Scholar
Ge T, Chen CY, Ni Y, Feng YA, Smoller JW. Polygenic prediction via Bayesian regression and continuous shrinkage priors. Nat Commun. 2019;10(1):1776.
Article PubMed PubMed Central Google Scholar
Friedman J, Hastie T, Tibshirani R. Regularization paths for generalized linear models via coordinate descent. J Stat Softw. 2010;33(1):1–22.
Article PubMed PubMed Central Google Scholar
Li Z, Wu X, Leo PJ, De Guzman E, Akkoc N, Breban M, et al. Polygenic risk scores have high diagnostic capacity in ankylosing spondylitis. Ann Rheum Dis. 2021;80(9):1168–74. Most comprehensive polygenic risk scores (PRS) in multiple ethnicities in ankylosing spondylitis demonstrating a high diagnostic capacity.
Article CAS PubMed Google Scholar
International Schizophrenia C, Purcell SM, Wray NR, Stone JL, Visscher PM, O’Donovan MC, et al. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature. 2009;460(7256):748–52.
Mavaddat N, Michailidou K, Dennis J, Lush M, Fachal L, Lee A, et al. Polygenic risk scores for prediction of breast cancer and breast cancer subtypes. Am J Hum Genet. 2019;104(1):21–34.
Article CAS PubMed Google Scholar
Cui Z, Hou G, Meng X, Feng H, He B, Tian Y. Bidirectional causal associations between inflammatory bowel disease and ankylosing spondylitis: a two-sample Mendelian randomization analysis. Front Genet. 2020;11:587876. A well-executed two-sample Mendelian randomization (MR) to estimate the unconfounded causal associations between inflammatory bowel disease and ankylosing spondylitis.
Article CAS PubMed PubMed Central Google Scholar
Burgess S, Butterworth A, Thompson SG. Mendelian randomization analysis with multiple genetic variants using summarized data. Genet Epidemiol. 2013;37(7):658–65.
Article PubMed PubMed Central Google Scholar
Bowden J, Davey Smith G, Burgess S. Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int J Epidemiol. 2015;44(2):512–25.
Article PubMed PubMed Central Google Scholar
Bowden J, Davey Smith G, Haycock PC, Burgess S. Consistent estimation in Mendelian randomization with some invalid instruments using a weighted median estimator. Genet Epidemiol. 2016;40(4):304–14.
Article PubMed PubMed Central Google Scholar
Hartwig FP, Davey Smith G, Bowden J. Robust inference in summary data Mendelian randomization via the zero modal pleiotropy assumption. Int J Epidemiol. 2017;46(6):1985–98.
Article PubMed PubMed Central Google Scholar
Qi G, Chatterjee N. Mendelian randomization analysis using mixture models for robust and efficient estimation of causal effects. Nat Commun. 2019;10(1):1941.
Article PubMed PubMed Central Google Scholar
Verbanck M, Chen CY, Neale B, Do R. Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases. Nat Genet. 2018;50(5):693–8.
Article CAS PubMed PubMed Central Google Scholar
Boehm FJ, Zhou X. Statistical methods for Mendelian randomization in genome-wide association studies: a review. Comput Struct Biotechnol J. 2022;20:2338–51. Reviewed recent development of Mendelian randomization methods in genome-wide association studies.
Article CAS PubMed PubMed Central Google Scholar
Karreman MC, Luime JJ, Hazes JMW, Weel A. The prevalence and incidence of axial and peripheral spondyloarthritis in inflammatory bowel disease: a systematic review and meta-analysis. J Crohns Colitis. 2017;11(5):631–42.
Mei J, Wei P, Zhang L, Ding H, Zhang W, Tang Y, et al. Impact of ankylosing spondylitis on stroke limited to specific subtypes: evidence from Mendelian randomization study. Front Immunol. 2022;13:1095622.
Article CAS PubMed Google Scholar
Chen S, Luo X, Zhao J, Liang Z, Gu J. Exploring the causality between ankylosing spondylitis and atrial fibrillation: a two-sample Mendelian randomization study. Front Genet. 2022;13: 951893.
Article PubMed PubMed Central Google Scholar
Hu S, Xing H, Wang X, Zhang N, Xu Q. Causal relationships between total physical activity and ankylosing spondylitis: a Mendelian randomization study. Front Immunol. 2022;13: 887326.
Article CAS PubMed PubMed Central Google Scholar
Jiang J, Shao M, Wu X. Vitamin D and risk of ankylosing spondylitis: a two-sample mendelian randomization study. Hum Immunol. 2022;83(1):81–5.
Article CAS PubMed Google Scholar
Sun X, Deng Y, Ma Y, Shao M, Ni M, Zhang T, et al. Common mineral nutrients in ankylosing spondylitis: a 2-sample Mendelian randomization study. Int J Rheum Dis. 2022;25(10):1129–36.
Article CAS PubMed Google Scholar
Bugaj B, Wielinska J, Swierkot J, Bogunia-Kubik K, Gorna K. VDR Polymorphic variants are related to improvements in CRP and disease activity in patients with axial spondyloarthritis that undergo anti-TNF treatment. Genes. 2022;13(10).
Bialy S, Iwaszko M, Swierkot J, Bugaj B, Kolossa K, Jeka S, et al. Th2 cytokines (interleukin-5 and -9) polymorphism affects the response to anti-TNF treatment in Polish patients with ankylosing spondylitis. International journal of molecular sciences. 2022;23(21).
Wielinska J, Swierkot J, Kolossa K, Bugaj B, Chaszczewska-Markowska M, Jeka S, et al. Polymorphisms within genes coding for IL-17A and F and their receptor as clinical hallmarks in ankylosing spondylitis. Mediators Inflamm. 2021;2021:3125922.
Article PubMed PubMed Central Google Scholar
Iwaszko M, Wielinska J, Swierkot J, Kolossa K, Sokolik R, Bugaj B, et al. IL-33 Gene polymorphisms as potential biomarkers of disease susceptibility and response to TNF inhibitors in rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis patients. Front Immunol. 2021;12: 631603.
Article CAS PubMed PubMed Central Google Scholar
Menon DK, Rosand J. Finding a place for candidate gene studies in a genome-wide association study world. JAMA Netw Open. 2021;4(7): e2118594.
Wang XB, Ellis JJ, Pennisi DJ, Song X, Batra J, Hollis K, et al. Transcriptome analysis of ankylosing spondylitis patients before and after TNF-alpha inhibitor therapy reveals the pathways affected. Genes Immun. 2017;18(3):184–90.
Article CAS PubMed Google Scholar
Ciechomska M, Bonek K, Merdas M, Zarecki P, Swierkot J, Gluszko P, et al. Changes in MiRNA-5196 expression as a potential biomarker of anti-TNF-alpha therapy in rheumatoid arthritis and ankylosing spondylitis patients. Arch Immunol Ther Exp. 2018;66(5):389–97.
Lim WK, Mathuru AS. Design, challenges, and the potential of transcriptomics to understand social behavior. Curr zool. 2020;66(3):321–30.
Comments (0)